TGRPTRON Group Inc.

About TRON Group Inc. (TGRP)

TRON Group Inc. (TGRP) is a Biotechnology company headquartered in Alachua, FL, United States whose shares trade over-the-counter on the Pink tier.

TRON Group Inc. (OTC: TGRP), through its subsidiaries, is a clinical-stage specialty pharmaceutical company developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, diabetes and infectious diseases. TRON Group Inc. subsidiaries include Nanopharmaceutics, Inc., a wholly-owned subsidiary, and Alchem Laboratories Corporation, a majority-owned subsidiary, both located in Alachua, Florida.

Products and services

Nanopharmaceutics, Inc. is a clinical-stage specialty pharmaceutical company developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, diabetes and infectious diseases. Alchem Laboratories Corporation performs discovery, development, and manufacturing of preclinical to clinical stage pharmaceutical programs.

TGRP key facts

Ticker symbol

TGRP

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Alachua, FL, United States

Country of incorporation

US

Year of incorporation

2015

Employees

20

Estimated market cap

$5.52M (as of Apr 15, 2025)

Shares outstanding

184,000,000

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

TRON Group Inc. leadership

• James David Talton — President, CEO, Secretary
• Judy C Talton — Acting CFO

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with T